The trade war has reshaped global semiconductor supply chains, forcing key players such as Taiwan Semiconductor Manufacturing Co, Intel, ASML and their massive network suppliers to either face curbs in selling or confine their operations to specific locations. While fewer headlines have been spun, the trade tensions are similarly affecting industries other than semiconductors.
For example, China-based healthcare players, including drug and equipment makers, will likely face curbs from a familiar foe. Under the US Biosecure Act, US companies must cut ties with certain Chinese partners, including those in existing production chains. As such, some outsourcing traditionally undertaken by China has been moving elsewhere. “Companies are proactively reducing their exposure to Chinese suppliers, even in healthcare,” says Yann Mauron, principal at Pictet Asset Management, in an interview with The Edge Singapore.
